IAPP and Cognitive impairment: Using ELISA, we measured amylin concentrations in blood samples collected from cognitively unimpaired individuals (CU; n = 42) and persons with sAD-type dementia (DEM; n = 19) or mild cognitive impairment (MCI; n = 19) (see Table 1 for summary statistics for age and sex).